Bristol Myers Squibb partners with BioNTech in a $11.1B deal to develop BNT327, a promising cancer immunotherapy. Read more ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

A week after one New Haven-based biotechnology company announced a mass layoff, another has announced plans to cut 40% of its workforce. RallyBio, based at 234 Church St., in New Haven ...

Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into aging, is now laying off every one of its remaining employees.

The company expects to lay off the majority of its workforce by the end of the second fiscal quarter, according to SEC filings. Mural Oncology is a biotechnology company that focuses on using its ...

After San Francisco biotech company Third Harmonic Bio slashed its staff by half in February, it’s now taking a more drastic step. The inflammatory disease research company’s directors have ...

A biotech company says it has bred three animals with key physical features of the dire wolf — a species that has been extinct for more than 12,000 years. Colossal Biosciences says it used novel ...

AmplifyBio, once one of central Ohio's most promising biotech firms, announced Friday that it has shut down. In a posting on its website, the company said the decision followed months of efforts ...

The staff reductions are slated to occur on May 27. — Roche Molecular Systems, a unit of pharmaceutical company Roche, 108 job cuts in Santa Clara. The layoffs are scheduled for May 28.

Biotech companies are innovators, which could translate into growth for your portfolio. It’s important to think long term and pay particular attention to a biotech’s pipeline -- today’s out ...

The Japanese pharmaceutical company Taiho Pharmaceutical is set to acquire the Swiss antibody-drug conjugate (ADC) company Araris Biotech for $400 million. Taiho and Araris have been collaborating ...

Biopharmaceutical company recognized for innovation in the development of immune-modulatory therapeutic cancer vaccines – NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq ...